UK pharma trade bodies, including the ABPI, have agreed a set of guidelines intended to address problems in supplying branded medicines. The guidance, 'Trading Medicines for Human Use: Shortages and
Supply Chain Obligations', in effect amounts to a reiteration ...
[Pharmafocus - 11/19/2009]